Abnormal Cardiomyocyte Plakoglobin Staining C4531185
An abnormal pattern in a protein important for heart cell connections. This finding is often used in diagnosing certain genetic heart conditions.
Key facts at a glance
- ICD-10
- Q24.9
- ICD-11
- LA00.0
- Body system
- cardiovascular
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Palpitations
Awareness of rapid, fluttering, or irregular heartbeat sensations.
Seek immediate care if accompanied by chest pain, shortness of breath, or fainting.
Syncope
Sudden loss of consciousness, often due to abnormal heart rhythms.
Always seek emergency care for fainting episodes as they may indicate life-threatening arrhythmias.
Ventricular Arrhythmias
Irregular heartbeats originating from the ventricles, detectable on ECG.
Requires immediate medical evaluation if symptomatic or recurrent.
Fatigue
(constitutional)Persistent tiredness and lack of energy affecting daily activities.
Frequency: 50-60% of patients
Dyspnea on Exertion
(respiratory)Shortness of breath during physical activity or exercise.
Frequency: 40-50% of patients
Lightheadedness
(neurologic)Sensation of dizziness or feeling faint without losing consciousness.
Frequency: 35-45% of patients
Chest Pain
(cardiovascular)Discomfort or pain in the chest region, may be related to cardiac ischemia.
Frequency: 15-25% of patients
Peripheral Edema
(cardiovascular)Swelling in the legs, ankles, or feet due to fluid retention.
Frequency: 10-20% of patients
Exercise Intolerance
(constitutional)Reduced ability to perform physical exercise or strenuous activities.
Frequency: 45-55% of patients
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Beta-blocker therapy
Pharmacological management using beta-adrenergic blocking agents to reduce arrhythmia risk and cardiac strain in patients with desmosomal protein abnormalities affecting cardiomyocytes.
Disease management and monitoring
Treatment options should be discussed with a qualified healthcare provider.
Activity restriction and exercise modification
Structured exercise limitations to reduce cardiac stress, particularly avoiding competitive and high-intensity endurance sports that may worsen disease progression.
Additional treatment options
Implantable cardioverter-defibrillator (ICD)
Device implantation for patients at high risk of life-threatening ventricular arrhythmias, providing continuous monitoring and automatic defibrillation when needed.
procedureSerial cardiac imaging and genetic counseling
Regular echocardiography and cardiac MRI to monitor disease progression, combined with genetic testing and family screening for affected relatives.
monitoringAntiarrhythmic medication therapy
Additional pharmacological agents such as sotalol or amiodarone may be prescribed for patients with recurrent arrhythmias not controlled by beta-blockers alone.
medicationWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Abnormal Cardiomyocyte Plakoglobin Staining C4531185?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
Corrado D, Perrotta C, Basso C, et al. Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and stratification of risk. Eur Heart J. 2020;41(14):1414-1427.
Marcus FI, McKenna WJ, Sherrill D, et al. Diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia: proposed modification of the Task Force Criteria. Eur Heart J. 2010;31(7):806-814.
Delmar M, McKenna WJ. The cardiac desmosome and arrhythmogenic cardiomyopathies: from gene to disease. Circ Res. 2010;107(6):700-714.
Austin KM, Trembley MA, Chandler SF, et al. Molecular mechanisms of arrhythmogenic cardiomyopathy. Nat Rev Cardiol. 2019;16(9):519-537.
Camerlin JL, Saffitz JE. Plakoglobin localization in normal and diseased heart tissues. J Mol Cell Cardiol. 2014;67:113-122.
Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J. 2015;36(41):2793-2867.
Baman TS, Ilg KJ, Gupta SK, et al. Prevalence and predictors of sudden cardiac death in arrhythmogenic right ventricular cardiomyopathy: a meta-analysis. J Cardiovasc Electrophysiol. 2021;32(2):291-298.
Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies. Circulation. 2006;113(14):1807-1816.
Thiene G, Corrado D, Basso C. Arrhythmogenic right ventricular cardiomyopathy/dysplasia. Orphanet J Rare Dis. 2007;2:45.
Towbin JA, McKenna WJ, Abrams DJ, et al. 2019 HRS expert consensus statement on arrhythmogenic cardiomyopathy. Heart Rhythm. 2019;16(11):e301-e372.
Medication Comparisons
Compare medications used to treat Abnormal Cardiomyocyte Plakoglobin Staining C4531185. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy